Inhibikase Therapeutics
IKT
#8978
Rank
C$0.27 B
Marketcap
C$1.97
Share price
-4.83%
Change (1 day)
-7.60%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Inhibikase Therapeutics CIK: 0001750149

Thumbnail Inhibikase Therapeutics 10-K Annual Report 2025

10-K Annual Report 2025

Language: English

View Annual Report (10-K)
Thumbnail Inhibikase Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Inhibikase Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Inhibikase Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Inhibikase Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Inhibikase Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)